Adaptive Biotechnologies Corporation
ADPT
$19.66
-$0.06-0.30%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 59.60% | 12.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 59.60% | 12.27% | |||
| Cost of Revenue | -56.91% | 148.15% | |||
| Gross Profit | 352.74% | -52.78% | |||
| SG&A Expenses | 0.17% | 2.26% | |||
| Depreciation & Amortization | 1.18% | 0.95% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.28% | 2.28% | |||
| Operating Income | 141.10% | 15.43% | |||
| Income Before Tax | 137.30% | 14.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 137.30% | 14.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 104.76% | 4.55% | |||
| Net Income | 137.27% | 14.20% | |||
| EBIT | 141.10% | 15.43% | |||
| EBITDA | 171.56% | 17.44% | |||
| EPS Basic | 137.17% | 15.84% | |||
| Normalized Basic EPS | 137.13% | 18.44% | |||
| EPS Diluted | 135.63% | 15.84% | |||
| Normalized Diluted EPS | 134.76% | 18.44% | |||
| Average Basic Shares Outstanding | 0.23% | 1.94% | |||
| Average Diluted Shares Outstanding | 7.29% | 1.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||